Skip to main content

Table 2 Comparison of treatment groups at baseline

From: A randomized placebo-controlled trial of the efficacy and safety of a terbinafine, florfenicol and betamethasone topical ear formulation in dogs for the treatment of bacterial and/or fungal otitis externa

   Osurnia Placebo P-Value
Number   190 94  
Age (mean (range); yrs 6.1 (0.3–16.4) 6.1 (0.3–15.8) 0.9097
Body weight <  40 lbs.; N (%) 78 (41%) 41 (44%) 0.8617
40–79 lbs.; n (%) 64 (34%) 32 (34%)
≥80 lbs.; n (%) 48 (25%) 21 (22%)
Gender F:M ratio 90:100 = 0.9 52:42 = 1.2 0.2564
Ears affected One ear; n (%) 17 (9%) 7 (7%) 0.8217
Two ears; n (%) 173 (91%) 87 (93%)
History of otitis Acute; n (%) 47 (25%) 29 (31%) 0.5436
Subchronic; n (%) 73 (38%) 32 (34%)
Chronic; n (%) 70 (37%) 33 (35%)
Exudate Type Erythematous/ceruminous; n (%) 158 (83%) 78 (83%) 1.000
Suppurative; n (%) 32 (17%) 16 (17%)
Frequency of Otitis Recurrent otitis; n (%) 22 (12%) 9 (10%) 0.6894
Hearing Loss Can hear at Day 0; n (%) 181 (97%) 90 (96%) 0.4846